Visfatin: a new player in mesangial cell physiology and diabetic nephropathy (Q28577873)

2

1 reference

31 January 2017

Bo Kyung Kim

3

1 reference

31 January 2017

Yun Gyu Park

4

1 reference

31 January 2017

Gang Jee Ko

5

1 reference

31 January 2017

Young Sun Kang

6

1 reference

31 January 2017

Jee Young Han

7

1 reference

31 January 2017

Sang Youb Han

8

1 reference

31 January 2017

Kum Hyun Han

9

1 reference

31 January 2017

Hyoung Kyu Kim

10

1 reference

31 January 2017

Dae Ryong Cha

American Journal of Physiology - Renal Physiology

11

1 reference

31 January 2017

1 November 2008

1 reference

31 January 2017

1 reference

31 January 2017

295

1 reference

31 January 2017

5

1 reference

31 January 2017

F1485–1494

1 reference

31 January 2017

Adipose tissue as an endocrine organ

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

The release of the adipocytokine visfatin is regulated by glucose and insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

TGF-beta 1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Visfatin: gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008

High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.90231.2008